Skip to content
Operation Infinite Justice – Lifestyle
Author:
Astellas Pharma Inc.
New Preliminary Real-World VEOZAH™ (fezolinetant) Data Highlights Improvements in Menopause-Related Symptoms and Sleep Outcomes
October 7, 2026
Astellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026
October 6, 2026
Astellas Doses First Patient in Phase 3 Study of setidegrasib in Previously Treated KRAS G12D-Mutated Advanced Non-Small Cell Lung Cancer
September 23, 2026
Astellas enters voluntary agreement with U.S. government supporting affordable access to medicines
August 31, 2026
Astellas to Spotlight New Research for Geographic Atrophy at ASRS 2026 Annual Meeting
July 9, 2026